Braidwell LP Buys New Stake in Danaher Corporation $DHR

Key Points

• Braidwell LP has made a significant investment of $63.41 million in Danaher Corporation, acquiring 309,339 shares in the first quarter, which represents 2.2% of its investment portfolio.
• Wall Street analysts have given Danaher a consensus rating of "Moderate Buy" with an average price target of $247.61, reflecting strong confidence in the company's growth trajectory.
• Despite recent insider selling, which saw Director Teri List reduce her position by 11.81%, institutional ownership remains high at 79.05% of the company's stock.

Braidwell LP purchased a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 309,339 shares of the conglomerate's stock, valued at approximately $63,414,000. Danaher makes up 2.2% of Braidwell LP's investment portfolio, making the stock its 16th largest holding.

A number of other large investors have also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. lifted its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares during the last quarter. Heck Capital Advisors LLC acquired a new position in Danaher in the fourth quarter valued at approximately $27,000. Sierra Ocean LLC lifted its holdings in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after acquiring an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new position in Danaher in the first quarter valued at approximately $31,000. Finally, Dunhill Financial LLC lifted its holdings in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently commented on the company. UBS Group decreased their price objective on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft decreased their price objective on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Robert W. Baird upped their price target on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Wells Fargo & Company decreased their price target on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Finally, Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Stock Up 0.6%

Shares of NYSE DHR traded up $1.29 during mid-day trading on Friday, hitting $200.32. The company had a trading volume of 2,837,584 shares, compared to its average volume of 2,859,442. The company has a market capitalization of $143.44 billion, a PE ratio of 42.62, a price-to-earnings-growth ratio of 2.78 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90. The business's 50-day simple moving average is $201.93 and its 200 day simple moving average is $199.41.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period last year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.